CompletedNCT06242288
Acne treatment and changes in depression-related blood markers
About this title
Read the official source — NCT06242288Medication studyAges 18–40Egypt
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
- Listed locations
- TantaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: January 30, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Mostafa Bahaa
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Egypt
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT06242288
- Official title
Show the full official title
Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tanta
Questions about this study
Who is behind this study?
The study sponsor is Mostafa Bahaa.
Did this study involve medication?
Yes. The study involved medication, including ISOtretinoin 20 MG.
Who was this study for?
Listed age limits: 18 years to 40 years.
